Emulating randomized trials: treading carefully and pushing the limits

This publication has 16 references indexed in Scilit:

• Improving the validity of noninterventional comparative effectiveness research by basing study design on a specified existing randomized controlled trial
  American Journal of Epidemiology, 2024
• Levothyroxine Treatment of Subclinical Hypothyroidism and the Risk of Adverse Cardiovascular Events
  Thyroid®, 2024
• Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan
  Advances in Therapy, 2024
• Biological Disease-Modifying Antirheumatic Drugs and Osteoporotic Fracture Risk in Patients with Rheumatoid Arthritis: A Danish Cohort Study
  The American Journal of Medicine, 2022
• Triple Therapy in COPD: Time for Adaptive Selection Trials
  COPD: Journal of Chronic Obstructive Pulmonary Disease, 2021
• Ten Commandments for Randomized Trials of Pharmacological Therapy for COPD and Other Lung Diseases
  COPD: Journal of Chronic Obstructive Pulmonary Disease, 2021
• Perplexing mortality data from triple therapy trials in COPD
  The Lancet Respiratory Medicine, 2021
• Effectiveness of Proton Pump Inhibitors in Idiopathic Pulmonary Fibrosis
  Chest, 2021
• Making Sense of Triple Inhaled Therapy for COPD
  New England Journal of Medicine, 2018
• Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores
  Pharmacoepidemiology and Drug Safety, 2016